Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock – Here’s Why

We recently published Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings. Gilead Sciences Inc (NASDAQ:GILD) is one of the top trending stocks to watch ahead of Nvidia earnings.

Rob Sechan from NewEdge Capital Group said in a recent program on CNBC that he’s buying Gilead Sciences Inc (NASDAQ:GILD) and explained his bullish case thesis in the following words:

“It’s up a good bit year to date, up like 28%. Still trades cheap. Very high quality company with a reasonable valuation. I think that change is just further success in that platform in which they’re starting to dominate and so this is a great way to get quality exposure at a reasonable price.”

Analyst Says Gilead (GILD) is a ‘Very High Quality’ Cheap Stock - Here’s Why

Gilead Sciences Inc (NASDAQ:GILD) is up 24% so far this year.

Impax US Sustainable Economy Fund stated the following regarding Gilead Sciences, Inc. (NASDAQ:GILD) in its Q1 2025 investor letter:

“Gilead Sciences, Inc. (NASDAQ:GILD) (Health Care) the company is owned due to its role in solving evolving heath care challenges through the development of new medical treatments for conditions as chronic diseases are on the rise. The company also has one of the highest systematic ESG scores in the portfolio. Gilead reported better-than-expected quarterly results, largely driven by strong revenue from its HIV franchise. The company also provided an optimistic earnings guidance for the next fiscal year, helping provide defensiveness amid a flurry of volatility.”

While we acknowledge the risk and potential of GILD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GILD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.